FeaturesSignalPricingFounders
Log inGet started free
J&

Johnson & Johnson Innovation – JJDC

Corporate VCActive

JJDC finds transformative ideas and helps them mature into real solutions for today’s patients.

Cambridge, United StatesFounded 2020jnjinnovation.com/jjdc
34
Investments
10
Exits
—
AUM
29.4%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Johnson & Johnson Innovation – JJDC.

Get started free

Investment Thesis & Strategy

JJDC, as a corporate venture capital arm, invests in various stages across the healthcare industry, seeking transformative ideas that can mature into solutions for patients.

Investment Activity

Deals per year over the last 15 years

1
2007
0
2008
0
2009
0
2010
0
2011
1
2012
0
2013
1
2014
1
2015
2
2016
1
2017
1
2018
0
2019
0
2020
4
2021

Portfolio Companies

Selected investments from their portfolio of 34 companies

C
Cellarity
Biotech · Series B, 2021
Active
V
Vivacitas Oncology
Biotech · Series A, 2021
Active
A
Alvine Therapeutics
Biotech · Series A, 2021
Active
E
ERA
Biotech · Series A, 2021
Active
F
Foghorn Therapeutics
Biotech · Series B, 2018
Active
L
Lava Therapeutics
Biotech · Series A, 2017
Active
L
Lyndra Therapeutics
Biotech · Series B, 2016
Active
S
Surface Oncology
Biotech · Series B, 2016
Active
G
GenSight Biologics
Biotech · Growth, 2015
Active
C
Cerecor
Biotech · Series A, 2014
Active
P
Protagonist Therapeutics
Biotech · Series A, 2012
Active
A
Achillion Pharmaceuticals
Biotech · Series A, 2007
Active

Notable Exits

CompanyTypeYearValue / Acquirer
Aurion BiotechAcquisition2024—
Momenta PharmaceuticalsAcquisition2020$6.5B
Celltrion HealthcareIPO2017—
Novira TherapeuticsAcquisition2015—
Ambit BiosciencesAcquisition2014$410M
Alios BioPharmaAcquisition2014$1.75B
Aragon PharmaceuticalsAcquisition2013$1B
ProteolixAcquisition2011$851M
CrucellAcquisition2011$2.4B
Cougar BiotechnologyAcquisition2009$970M

Frequently Asked Questions

Johnson & Johnson Innovation – JJDC focuses on Series A, Series B stage investments.

Related Investors

SR One

Cambridge, United States · 144 deals

Sanofi Ventures

Cambridge, United States · 37 deals

Johnson & Johnson Innovation вАУ JJDC

Cambridge, United States · 34 deals

Baxalta Ventures

Cambridge, United States · 6 deals

Partners HealthCare Innovation

Cambridge, United States · 1 deals

Brand Capital

Mumbai, India · 570 deals